help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 72, No. 2 438-443
doi:10.1210/jcem-72-2-438
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GUNDBERG, C. M.
Right arrow Articles by LEBOFF, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUNDBERG, C. M.
Right arrow Articles by LEBOFF, M. S.

Acute Changes in Serum Osteocalcin during Induced Hypocalcemia in Humans*

CAREN M. GUNDBERG, FREDRICK D. GRANT, PAUL R. CONLIN, CHU J CHEN, EDWARD M. BROWN, PAMELA J. JOHNSON and MERYL S. LEBOFF

Department of Orthopaedics (C.M.G., P.J.J.), Yale University School of Medicine New Haven, Connecticut 06115
The Endocrine-Hypertension Division and the Department of Medicine (F.D.G, P.R.C, C.J.C., E.M.B., M.S.L), Brigham and Women's Hospital Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Caren M. Gundberg, Department of Orthopaedics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticutt 06510.

Although levels of serum osteocalcin are thought to be an indicator of osteoblastic activity and bone formation, there is little information regarding the acute effects of changes in calcium or PTH levels on circulating osteocalcin concentrations. To study the effect of stepwise decreases in ionized calcium (Ca1) on osteocalcin levels, we infused six normal subjects with citrate for four 30-min intervals using two different protocols. One protocol (pulse infusion) used alternating rates of infusion and resulted in rapid stepwise decrements in serum Ca1. The second protocol (continuous infusion) used constant intermediate rates of citrate infusion and produced slower decrements in Ca1, but with similar changes in magnitude. We monitored serum Ca1, intact PTH, and osteocalcin concentrations during the course of these infusions.

During each step of the pulse infusion the osteocalcin responses to changes in Ca1 in general were parallel to the changes in PTH (r = 0.462; P = 0.02) and were inversely correlated to Ca1 (r = –0.562; P = 0.003). Thn osteocalcin concentrations at the end of each 30-min period were higher than at the beginning of that period; over the total l20 min, osteocalcin levels rose from 3.46 ± 0.63 to 6.88 ± 1.08 µg/L (P < 0.05). In contrast, during the first two periods of the continuous infusion, osteocalcin concentrations changed slightly. Only during the last two periods of the continuous infusion did osteocalcin respond in a manner characteristic of that observed with the pulse infusion. These data indicate that osteocalcin concentrations in the circulation may be acutely regulated by calcium and/or PTH.

* This work was supported by NIH Grants 5-RO1-AR-38460, 5-ROl-DK-36796, and 5-RO1-DK-41415; Research Career Development Award 5-KO4-AR-01789; the Training Program in Endocrinology (5-T32-DK-07529); the Training Program in Hypertension (5-T3207609); and Specialized Center of Research in Hypertension Grant 2-P50-HL-36568.

Received June 2, 1990.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Kantham, S. J. Quinn, O. I. Egbuna, K. Baxi, R. Butters, J. L. Pang, M. R. Pollak, D. Goltzman, and E. M. Brown
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E915 - E923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. K. Ivaska, T. A. Hentunen, J. Vaaraniemi, H. Ylipahkala, K. Pettersson, and H. K. Vaananen
Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro
J. Biol. Chem., April 30, 2004; 279(18): 18361 - 18369.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. Glowacki, S. Hurwitz, T. S. Thornhill, M. Kelly, and M. S. LeBoff
Osteoporosis and Vitamin-D Deficiency Among Postmenopausal Women with Osteoarthritis Undergoing Total Hip Arthroplasty
J. Bone Joint Surg. Am., December 1, 2003; 85(12): 2371 - 2377.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Patterson-Buckendahl, M. Rusnak, K. Fukuhara, and R. Kvetnansky
Repeated immobilization stress reduces rat vertebral bone growth and osteocalcin
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R79 - R86.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. S. LeBoff, L. Kohlmeier, S. Hurwitz, J. Franklin, J. Wright, and J. Glowacki
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
JAMA, April 28, 1999; 281(16): 1505 - 1511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society